Netherlands· NL-eb7bb277cb71

Cimetidine Accord 200 mg, filmomhulde tabletten

A cimetidine product containing cimetidine, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC A02BA01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cimetidineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cimetidine is registered in 11 of 19 countries.

Countries holding a registration under ATC A02BA01 (cimetidine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
5 of them publish a price we can compare per daily dose

Search cimetidine products by name

Cimetidine · ATC A02BA01

11 / 19 countries

Belgiumprice
Canada
Finlandprice
Franceprice
Germany
Ireland
Japan
Netherlands
Norwayprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cimetidine costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cimetidine · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

FR France$1.63

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CIMETIDINE
Manufacturer: Accord Healthcare B.V.
Country: Netherlands (NL)
ATC code: A02BA01
ATC class: Cimetidine
Defined daily dose: 0.8 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
24021

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

678 interactions on record for cimetidine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cimetidine against other medicines How interaction checks work

Cimetidine · interactions on record

678 records

35 severe
311 moderate
153 minor
169 info

Most severe, free to view

CisaprideA03FA02severe
LoperamideA07DA03severe
EliglustatA16AX10severe
LonafarnibA16AX20severe

10 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cimetidine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cimetidine products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

Austria · Cimetidin Genericon, Ulcostad
Cyprus · Tenomet, Ulcomet
Germany · H2-Blocker Ratiopharm
France · Cimetidine Arrow
United Kingdom (Northern Ireland) · Cimetidine Accord Healthcare, Cimetidine Bristol Laboratories
Greece · Tagamet
Ireland · Cimeldine Clonmel Healthcare
Luxembourg · H2blocker
Portugal · Cim.
Romania · Cimetidina Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/90616d59-6de0-45d5-95ce-dc39caaffb21
GET /v1/drugs/90616d59-6de0-45d5-95ce-dc39caaffb21?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h24021_smpc.pdf",
  "strength": null,
  "atc_label": "Cimetidine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg24021",
  "excipients": [
    "CHINOLINEGEEL ALUMINIUMLAK (E 104)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "CIMETIDINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h24021.pdf",
  "authorised_at": "1999/02/23",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "24021",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about cimetidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console